Form 4: Assertio CEO Granted Significant Equity Awards

Assertio Holdings, Inc. CEO Mark L. Reisenauer received grants of 500,000 restricted stock units and 1,000,000 stock options.

Summary

• Mark L. Reisenauer, CEO and Director of Assertio Holdings, Inc. (ASRT), was granted 500,000 Restricted Stock Units (RSUs) and 1,000,000 Stock Options.
• The grant date for both derivative securities was November 13, 2025.
• Each RSU represents a contingent right to receive one share of the registrant's common stock, with no consideration paid by the reporting person.
• The stock options have an exercise price of $0.8248 per share, with no consideration paid by the reporting person.
• Both the RSUs and stock options are scheduled to vest one-third on each of the first three anniversaries of the grant date, contingent on continued employment.
• The stock options have an expiration date of November 13, 2035.

Sentiment

Score: 7

Explanation: The grant of equity awards to the CEO is generally positive as it aligns management's interests with long-term shareholder value and promotes retention. However, it also introduces potential future dilution, leading to a moderately positive sentiment rather than strongly positive.

Positives

• The equity grants align the CEO's long-term interests with those of shareholders, incentivizing sustained company performance.
• The vesting schedule over three years promotes executive retention and commitment to the company's strategic goals.

Negatives

• The issuance of new shares upon vesting and exercise of these awards will result in dilution for existing shareholders.

Risks

• The value of the granted equity is subject to the future market price of Assertio Holdings, Inc. common stock, which can fluctuate.
• Vesting of the restricted stock units and stock options is contingent upon Mark L. Reisenauer's continued employment through the applicable vesting dates.

Future Outlook

The equity grants signal a long-term commitment from the CEO to the company's performance and shareholder value, with vesting tied to continued employment over the next three years.

Management Comments

• The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.

Industry Context

Executive equity grants, such as restricted stock units and stock options, are a standard component of compensation packages in publicly traded companies across various industries, designed to align management incentives with long-term shareholder interests.

Comparison to Industry Standards

• The practice of granting equity awards to executive officers is a common industry standard for compensation and retention.
• The filing does not provide specific comparable data regarding the size or terms of these grants relative to other companies in the pharmaceutical or specialty pharma sector, or against global benchmarks.

Related Party Transactions

• The grant of equity awards to Mark L. Reisenauer, the CEO and a Director, constitutes a related party transaction as part of his executive compensation.

Stakeholder Impact

• Shareholders: Potential for future dilution from the vesting and exercise of these awards, but also increased alignment of the CEO's interests with long-term shareholder value.
• Employees: No direct impact on general employees is mentioned in this filing.

Next Steps

• The Restricted Stock Units and Stock Options will vest in three equal annual installments on the anniversaries of the grant date, subject to continued employment.

Key Dates

Recommendation

The equity grants to the CEO are a standard compensation practice that aligns management's incentives with long-term shareholder value, which is a positive. However, the potential for future dilution from these awards, without additional financial or operational updates, suggests a neutral 'hold' stance based solely on this compensation filing. Investors should consider broader company performance and market conditions.

Keywords

Assertio Holdings, ASRT, Mark L. Reisenauer, CEO, Director, Stock Options, Restricted Stock Units, Equity Grant, Executive Compensation, SEC Form 4